Pomerantz LLP is investigating claims on behalf of investors of Allbirds, Inc. (“Allbirds” or the “Company”) (NASDAQ: BIRD).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Allbirdsand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information […]

Chicago, Illinois, March 31, 2025 (GLOBE NEWSWIRE) — Entrepreneurship is often glamorized as a thrilling, rewarding journey. But few talk about the self-doubt, isolation, and immense mental strain that comes with it. Even the most successful entrepreneurs battle imposter syndrome, questioning whether their achievements were luck or a fluke. CEO of Gemini Builds It and

Pomerantz LLP is investigating claims on behalf of investors of Xponential Fitness, Inc. (“Xponential” or the “Company”) (NYSE: XPOF).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Xponentialand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for

Pomerantz LLP is investigating claims on behalf of investors of KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether KinderCareand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here

Brown Gibbons Lang & Company (BGL), a leading independent investment bank and financial advisory firm, is pleased to announce the real estate sale of Dermatology Associates of Georgia Portfolio (DAG), totaling approximately 26,277 rentable square feet in Decatur, Suwanee, and Monroe, Georgia, to TM Medical Properties, LLC. BGL's Healthcare Real Estate team served as consultants

Familiar characters from Liberty Mutual, Allstate and Progressive were standouts for their consistent brand cues, humor and likability according to MarketCast's data MarketCast, a global marketing research firm, has released its latest insights into the performance of U.S. insurance brand mascots in advertising. The findings, derived from MarketCast Brand Effect platform that surveys 20,000 real

LinkSquares also ranked #1 in G2 Spring Mid-Market Grid® for CLM LinkSquares today announced that the company has been named a Leader in the Spring 2025 Grid for Contract Lifecycle Management (CLM) by G2, the world's largest and most trusted software marketplace. This recognition is based on the responses of real users for each of

Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether OSIand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for

Pomerantz LLP is investigating claims on behalf of investors of Pony AI Inc. (“Pony” or the “Company”) (NASDAQ: PONY).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Ponyand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for

(NYSE MKT:ATNM), SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Actinium Pharmaceuticals, Inc. (NYSE: ATNM) securities between October 31, 2022 and August 2, 2024. Actinium is a late-stage biopharmaceutical company that develops targeted